Breast Cancer Canada is inviting applications for its 2026 Research Grant Competition, offering a total of 250,000 CAD to advance precision oncology in Lobular Carcinoma. This national initiative supports cutting-edge, Canadian-led projects focused on improving diagnostics and targeted treatments through innovation in AI-driven research, precision medicine, and patient-centered collaboration.
Eligibility Criteria:
-
Applicants must be Canadian researchers or research teams affiliated with an eligible Canadian academic, medical, or research institution.
- Projects must focus on Lobular Carcinoma and align with one or more of the following areas:
- Precision diagnostics (screening, detection, or follow-up).
- Targeted treatment (surgery, medicine, or radiation).
-
Applications must include an active patient partner—preferably a breast cancer survivor or advocate diagnosed with Lobular Carcinoma.
-
Projects should demonstrate scientific rigor, feasibility, and measurable impact on breast cancer outcomes.
Funding Details:
-
Total available funding: 250,000 CAD.
- Grant tiers:
-
Category 1: 75,000 CAD (3 × 25,000 CAD annually).
-
Category 2: 50,000 CAD (2 × 25,000 CAD annually).
-
-
Funding duration: 2–3 years, depending on the chosen category.
-
Eligible expenses include personnel, research materials, data analysis tools, and patient engagement activities.
Deadline:
-
Letter of Intent (LOI) due: December 12, 2025 (5 PM PT).
-
Letters of Invitation issued: December 19, 2025.
-
Full proposal (NOI) due: February 13, 2026 (5 PM PT).
-
Notice of decision: April 17, 2026.
-
Grant announcement: May 2026 (ASCO Congress, date TBC).
-
Funding start date: June 30, 2026.
Where to Go For Further Information:
- Email [email protected] to submit your Letter of Intent (LOI).
- Program details.